Sort
53,477 grants matching “addiction”
HEAL: New Chemical Structures for Pain, Addiction and Overdose Targets
$2,389,171Samuel Michael · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
$2,386,858Charles Bradberry · National Institute On Drug Abuse · ZIA · FY2021 · DA
Decision Making and HIV Risk: New Approaches to neuroAIDS Research in Drug Users
$2,385,000Christina S Meade · Duke University · DP2 · FY2015 · DA
A novel therapeutic to ameliorate chronic pain and reduce opiate use
$2,382,426Boris Tabakoff · Lohocla Research Corporation · UG3 · FY2019 · DA
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES
$2,381,626Rockefeller University · P60 · FY2002 · DA
Oklahoma Center for Microbiome Research
$2,381,601Tyrrell Conway · Oklahoma State University Stillwater · P20 · FY2024 · GM
Center for Systems Neurogenetics of Addiction
$2,381,552Elissa J Chesler · Jackson Laboratory · P50 · FY2017 · DA
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity
$2,381,424James J Hickman · University Of Central Florida · UH3 · FY2021 · TR
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$2,380,406Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2022 · DA
Project-002
$2,380,344Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$2,380,269Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2023 · DA
Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder
$2,378,184Christian Arthur Heidbreder · Indivior, Inc. · UH3 · FY2023 · DA
COBRE Center on Opioids and Overdose
$2,376,689Josiah D Rich · Rhode Island Hospital · P20 · FY2020 · GM
Case GI SPORE
$2,375,000Sanford D Markowitz · Case Western Reserve University · P50 · FY2017 · CA
Case GI SPORE
$2,375,000Sanford D Markowitz · Case Western Reserve University · P50 · FY2020 · CA
GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION
$2,373,164John R Hoidal · University Of Utah · P01 · FY2006 · HL
A Developmental Model of Gene-Environment Interplay in SUDs
$2,372,251Elizabeth J Costello · Duke University · U01 · FY2010 · DA
Identification and validation of LPA/LPAR signaling as a target for the treatment of temporomandibular disorder pain
$2,372,116Yong Chen · Duke University · R01 · FY2024 · DE
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)
$2,371,942Joanna L. Starrels · Albert Einstein College Of Medicine · RM1 · FY2024 · DA
RESEARCH ON TREATMENT AND PREVENTION OF IV DRUG ABUSE
$2,370,401University Of Pennsylvania · P60 · FY2000 · DA
ENIGMA Center for Worldwide Medicine, Imaging & Genomics
$2,369,482Paul M Thompson · University Of Southern California · U54 · FY2017 · EB
ENIGMA Center for Worldwide Medicine, Imaging & Genomics
$2,369,463Paul M Thompson · University Of Southern California · U54 · FY2016 · EB
Center for Biomedical Research Excellence, Epigenomics of Development and Disease
$2,368,344Roxanne A Vaughan · University Of North Dakota · P20 · FY2013 · GM
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man
$2,367,195Patricia Sue Grigson · Pennsylvania State Univ Hershey Med Ctr · UG3 · FY2019 · DA
ENIGMA Center for Worldwide Medicine, Imaging & Genomics
$2,366,897Paul M Thompson · University Of Southern California · U54 · FY2015 · EB